Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women: A Multicenter Randomized Controlled Trial

NCT06952712 is registered in ClinicalTrials.gov with FANG HE as lead sponsor.

NCT NCT06952712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06952712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women: A Multicenter Randomized Controlled Trial
Lead sponsor
FANG HE
Phase
Phase 3
Overall status
Not yet recruiting
Start date
May 7, 2025
Completion date
May 6, 2028
Enrollment
1,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia